IgA Antibody |
49423-100ul |
SAB |
100ul |
EUR 399.6 |
Iga Antibody Laboratories manufactures the transglutaminase antibody iga icd10 reagents distributed by Genprice. The Transglutaminase Antibody Iga Icd10 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact iga antibody. Other Transglutaminase products are available in stock. Specificity: Transglutaminase Category: Antibody Group: Iga Icd10
Iga Icd10 information
Transglutaminase 2 Antibody |
33505-100ul |
SAB |
100ul |
EUR 302.4 |
Transglutaminase 2 Antibody |
33505-50ul |
SAB |
50ul |
EUR 224.4 |
Transglutaminase 2 Antibody |
49721-100ul |
SAB |
100ul |
EUR 399.6 |
Transglutaminase 2 Antibody |
49721-50ul |
SAB |
50ul |
EUR 286.8 |
Transglutaminase 7 Antibody |
DF14370 |
Affbiotech |
100ul |
EUR 420 |
Transglutaminase 2 Antibody |
F50805-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. TGM2 acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. It has been identified as the autoantigen implicated in celiac disease. |
Transglutaminase 2 Antibody |
F50805-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. TGM2 acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. It has been identified as the autoantigen implicated in celiac disease. |
Transglutaminase 2 Antibody |
F54953-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
Description: Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. TGM2 acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. It has been identified as the autoantigen implicated in celiac disease. |
Transglutaminase 2 Antibody |
F54953-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
Description: Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. TGM2 acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. It has been identified as the autoantigen implicated in celiac disease. |
Transglutaminase 3 Antibody |
R36205-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: TGM3, TG3 |
Transglutaminase 4 Antibody |
R34890-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: TG4; TGM4 |
Transglutaminase 2 Antibody |
R31273 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: Transglutaminase 2, also called TGC, TG2 and TGM2, is a 78-kDa, calcium dependent enzyme of the protein-glutamine gamma-glutamyltransferases family. Transglutaminases (TGs) are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of TGs are not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. Transglutaminase 2 acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. It is the autoantigen implicated in celiac disease. |
Transglutaminase 2 Antibody |
R32370 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: Transglutaminase 2, also called TGC, TG2 and TGM2, is a 78-kDa, calcium dependent enzyme of the protein-glutamine gamma-glutamyltransferases family. Transglutaminases (TGs) are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of TGs are not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. Transglutaminase 2 acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. It is the autoantigen implicated in celiac disease. |
Transglutaminase 6 Antibody |
R33519-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: Transglutaminase 6; Tgm6; Tg6 |
Transglutaminase 2 Antibody |
R33953-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: TGM2; TG2 |
Transglutaminase 2 Antibody |
V2890-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Recognizes a 77-85kDa protein, identified as cellular or tissue transglutaminase II (TGase II). Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. The protein encoded by this gene acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. Finally, the encoded protein is the autoantigen implicated in celiac disease. The identification of transglutaminase as the main antigen of endomysium antibodies allows a new diagnostic approach to celiac disease (CD), a genetic, immunologically mediated small bowel enteropathy that causes malabsorption. TGase II is implicated in programmed cell death, signal transduction, drug-resistance, cell growth, endocytosis, insulin secretion, cell adhesion, cataract formation, and wound healing. |
Transglutaminase 2 Antibody |
V2890-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Recognizes a 77-85kDa protein, identified as cellular or tissue transglutaminase II (TGase II). Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. The protein encoded by this gene acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. Finally, the encoded protein is the autoantigen implicated in celiac disease. The identification of transglutaminase as the main antigen of endomysium antibodies allows a new diagnostic approach to celiac disease (CD), a genetic, immunologically mediated small bowel enteropathy that causes malabsorption. TGase II is implicated in programmed cell death, signal transduction, drug-resistance, cell growth, endocytosis, insulin secretion, cell adhesion, cataract formation, and wound healing. |